Skip to main navigation
Skip to search
Skip to main content
Mayo Clinic Home
Search content at Mayo Clinic
Home
Profiles
Departments/Divisions
Grants
Research output
Prizes
SPIROMICS Genetics & Informatics Center (GIC)
Steingrub, Jay
(CoPI)
Fuhlbrigge, Anne Louise
(CoPI)
Fuhlbrigge, Anne L.
(CoPI)
Wiedemann, Herbert P.
(CoPI)
Gaeke Torrence, Christine
(CoPI)
Marathe, Anita
(CoPI)
Thompson, Bruce
(CoPI)
Barr, Graham
(CoPI)
Albert, Richard K.
(CoPI)
Macintyre, Neil R.
(CoPI)
Morris, Alan H.
(CoPI)
Brower, Roy
(CoPI)
Tonascia, James A.
(CoPI)
Stibolt, Thomas
(CoPI)
Casaburi, Richard
(CoPI)
Deboisblanc, Bennett P.
(CoPI)
Schoenfeld, D.
(CoPI)
Bartholmai, Brian Jack
(CoPI)
Hubmayr, Rolf Dieter
(CoPI)
Limper, Andrew Harold
(CoPI)
Limper, Andrew Harold
(CoPI)
Sullivan, Diane
(CoPI)
Diaz, Philip T.
(CoPI)
Criner, Gerard J.
(CoPI)
Couper, David J.
(PI)
Couper, David J.
(CoPI)
Cooper, Allen J. D.
(CoPI)
Kleerup, Eric C.
(CoPI)
Matthay, Michael A.
(CoPI)
Matthay, Michael A.
(CoPI)
Woodruff, Prescott G.
(CoPI)
Moss, M.
(CoPI)
Hoffman, Eric
(CoPI)
Martinez, null A.
(CoPI)
Martinez, Fernando J.
(CoPI)
Maxwell, Terri
(CoPI)
Gay, Steven
(CoPI)
Han, Meilan
(CoPI)
Sciurba, Frank
(CoPI)
Kanner, Richard
(CoPI)
Au, David
(CoPI)
Hough, Terri
(CoPI)
Wheeler, Arthur P.
(CoPI)
Bleecker, Eugene
(CoPI)
Hite, Duncan R.
(CoPI)
Motoki, Connie
(CoPI)
Radiology
Pulmonary and Critical Care Medicine
Pulmonary Medicine
Project
:
Research project
Overview
Fingerprint
Fingerprint
Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.
Sort by
Weight
Alphabetically
Keyphrases
Chronic Obstructive Pulmonary Disease
100%
CT Images
100%
Clinical Centers
83%
Clinical Trials
66%
Informatics
66%
Lung Disease
33%
Biospecimens
33%
Imaging Techniques
33%
Data Management
33%
Image Dataset
33%
Overall Management
33%
Molecular Fingerprinting
33%
Markers of Disease Severity
33%
Radiology
33%
High-throughput
33%
Bioinformatics Resources
33%
Molecular Data
33%
Surrogate Marker
33%
Pharmacology, Toxicology and Pharmaceutical Science
Chronic Obstructive Lung Disease
100%
Clinical Study
50%
Disease Severity
25%
Clinical Trial
25%
Clinical Research
25%
Disease Marker
25%
Lung Disease
25%